Arash Naziripour Selected Research

ONO 8713

1/2020

Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer's Disease Mouse Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arash Naziripour Research Topics

Disease

2	Inflammation (Inflammations) 01/2021 - 01/2019
1	Malnutrition (Nutritional Deficiencies) 11/2022
1	COVID-19 01/2021
1	Infections 01/2021
1	Coronavirus Infections 01/2021
1	Ischemic Stroke 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Stroke (Strokes) 01/2020
1	Gliosis 01/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020
1	Colitis 01/2019

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 11/2022 - 01/2021
1	Amino Acids FDA Link 11/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2022
1	remdesivirIBA 01/2021
1	Viral ProteinsIBA 01/2021
1	nafamostatIBA 01/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	ProstaglandinsIBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	ONO 8713IBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	gluconic acid (gluconate)FDA LinkGeneric 01/2019